Company Overview
Solstice Advanced Materials, Inc. functions as a specialty chemicals and advanced materials company with a global footprint that spans both domestic and international markets. The organization is categorized within the Basic Materials sector and specifically operates in the Specialty Chemicals industry, which involves the production of high-value materials essential for various industrial applications. This entity employs a workforce of 4,100 individuals and holds a market capitalization of $11.91B while generating $3.89B in annual revenue. These financial metrics indicate that the company operates at a significant scale, positioning it as a major player capable of influencing market dynamics within its specialized segments.
Financial Health
The company reported revenue of $3.89B and net income of $237.00M for the trailing twelve months, with an EBITDA of $927.00M. The substantial gap between the $3.89B in revenue and the $237.00M in net income reveals a cost structure where operating expenses and taxes consume a significant portion of gross sales before reaching the bottom line. However, the EBITDA figure of $927.00M suggests that the company generates strong operating cash flow before accounting for interest, taxes, depreciation, and amortization. Despite this operational strength, the free cash flow stands at $-23,625,000, indicating that the company is currently investing heavily in capital expenditures or working capital, which limits immediate financial flexibility but may support long-term expansion. The gross margin is 32.2%, reflecting the pricing power and cost efficiency in producing specialty chemicals, while the operating margin of 12.0% demonstrates effective control over administrative and selling expenses. The profit margin of 6.1% further illustrates the final profitability after all costs, taxes, and interest are deducted. On the balance sheet, the company holds $534.00M in cash against $2.54B in debt, resulting in a debt-to-equity ratio of 184.24, which characterizes a highly leveraged financial position rather than a conservative one. The current ratio is 1.39, indicating that the company possesses sufficient liquid assets to cover its short-term liabilities, though the margin is relatively tight. Additionally, the return on equity is 12.5% and the return on assets is 8.6%, metrics that reveal management's effectiveness in generating profits from shareholder investments and total assets respectively.
Valuation Assessment
The trailing twelve-month P/E ratio is 50.36, while the forward P/E is 23.86, implying that the market expects earnings growth to nearly double in the future to justify the current price valuation. The price-to-book ratio stands at 8.44, indicating that the market values the company at more than eight times its book value, suggesting a high premium assigned to its intangible assets or growth prospects. Alternative valuation metrics such as the price-to-sales ratio of 3.07 and an EV/EBITDA of 14.97 provide context that the stock is priced at a premium relative to both sales and earnings power. The stock has traded between a 52-week high of $84.44 and a 52-week low of $40.43, and without a specific current price provided in the facts, the valuation range establishes the volatility band within which the stock has moved over the past year. The beta is listed as N/A, which means that standard volatility metrics relative to the broader market are not disclosed in the available data, preventing a direct assessment of systematic risk compared to the index.
Growth & Income
The company experienced revenue growth of 8.1% year-over-year, whereas earnings growth was -69.3% year-over-year, indicating that earnings are currently growing significantly slower than revenue, likely due to the negative free cash flow and high leverage mentioned in the financial health section. For dividend payers, the dividend yield is 0.4% and the payout ratio is 0.0%, which explains that the company does not distribute any dividends to shareholders. Since the payout ratio is 0.0%, the company reinvests all of its earnings back into the business rather than paying out cash to investors, a strategy often seen in companies with high debt or significant capital needs. This approach suggests a growth-oriented capital allocation policy where Solstice prioritizes internal expansion and debt management over immediate shareholder returns.